Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8542386 | Journal of Pharmacy Research | 2013 | 5 Pages |
Abstract
Efavirenz significantly alters the pharmacokinetics of amodiaquine, exposure to amodiaquine is increased leading to toxic effect, and reduction in the antimalarial activity since amodiaquine is a prodrug that relies on its active metabolite against malaria parasites.
Related Topics
Health Sciences
Pharmacology, Toxicology and Pharmaceutical Science
Pharmacology, Toxicology and Pharmaceutics (General)
Authors
Julius O. Soyinka, Cyprian O. Onyeji, Thomas I. Nathaniel, Olugbenga O. Odunfa, Benjamin U. Ebeshi,